Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
0.3727
Dollar change
-0.0320
Percentage change
-7.91
%
Index- P/E- EPS (ttm)-0.24 Insider Own6.82% Shs Outstand180.72M Perf Week7.72%
Market Cap67.36M Forward P/E6.78 EPS next Y0.06 Insider Trans0.00% Shs Float168.40M Perf Month-20.62%
Income-39.77M PEG- EPS next Q-0.05 Inst Own16.91% Short Float7.38% Perf Quarter-58.89%
Sales0.00M P/S- EPS this Y2.27% Inst Trans6.97% Short Ratio9.39 Perf Half Y-47.28%
Book/sh0.47 P/B0.79 EPS next Y125.58% ROA-36.91% Short Interest12.42M Perf Year-50.48%
Cash/sh0.10 P/C3.76 EPS next 5Y- ROE-41.76% 52W Range0.33 - 1.07 Perf YTD-50.73%
Dividend Est.- P/FCF- EPS past 5Y28.21% ROI-46.36% 52W High-65.17% Beta1.63
Dividend TTM- Quick Ratio6.75 Sales past 5Y0.00% Gross Margin- 52W Low12.94% ATR (14)0.04
Dividend Ex-Date- Current Ratio6.75 EPS Y/Y TTM-18.36% Oper. Margin0.00% RSI (14)39.93 Volatility8.67% 9.18%
Employees22 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-13.79% Payout- Rel Volume0.34 Prev Close0.40
Sales Surprise- EPS Surprise-20.00% Sales Q/Q- EarningsAug 12 AMC Avg Volume1.32M Price0.37
SMA20-2.91% SMA50-21.68% SMA200-44.14% Trades Volume455,656 Change-7.91%
Date Action Analyst Rating Change Price Target Change
Nov-30-21Initiated Maxim Group Buy $4
Sep-05-24 04:30PM
08:30AM
Aug-13-24 09:30AM
04:32AM
Aug-12-24 10:53PM
05:28PM Loading…
05:28PM
04:22PM
08:00AM
Aug-09-24 07:30AM
Aug-08-24 05:41PM
06:59AM
Aug-05-24 08:00AM
08:00AM
Jul-18-24 07:00AM
Jul-17-24 08:00AM
11:00AM Loading…
Jul-11-24 11:00AM
08:00AM
Jul-10-24 09:10AM
Jul-07-24 09:01AM
Jun-11-24 10:50AM
May-29-24 08:30AM
May-21-24 11:42AM
11:20AM
10:58AM
07:00AM
May-14-24 10:55PM
04:05PM
May-10-24 08:30AM
Apr-30-24 04:05PM
Apr-26-24 10:43AM
08:00AM Loading…
08:00AM
Apr-11-24 08:30AM
Apr-04-24 08:30AM
Mar-18-24 08:30AM
Mar-12-24 10:30AM
Mar-07-24 08:30AM
Feb-26-24 07:30AM
Feb-23-24 08:30AM
Feb-15-24 09:17AM
Feb-14-24 04:30PM
08:01AM
Jan-23-24 08:30AM
Jan-02-24 08:31AM
08:30AM
Nov-14-23 08:55AM
Nov-09-23 08:30AM
Oct-31-23 08:45AM
Oct-24-23 07:30AM
Sep-21-23 09:35AM
Sep-18-23 04:30PM
Sep-13-23 04:30PM
Sep-08-23 08:00AM
Sep-06-23 04:30PM
Aug-14-23 04:15PM
Aug-10-23 08:37AM
Jul-29-23 04:16PM
Jun-26-23 08:30AM
Jun-20-23 04:09PM
08:30AM
Jun-13-23 08:30AM
May-12-23 04:30PM
May-08-23 01:42PM
May-04-23 08:00AM
Apr-24-23 09:10AM
Apr-03-23 08:00AM
Mar-30-23 08:30AM
Mar-27-23 09:52AM
Mar-13-23 09:15AM
Mar-08-23 08:30AM
Feb-10-23 04:30PM
Feb-06-23 10:30AM
Jan-17-23 10:00AM
Jan-16-23 07:09AM
Jan-11-23 08:30AM
Dec-28-22 09:35AM
Dec-22-22 04:30PM
Dec-01-22 07:30AM
Nov-21-22 08:00AM
Nov-09-22 08:30AM
Oct-18-22 08:30AM
07:59AM
Oct-06-22 04:30PM
Sep-28-22 08:30AM
Sep-23-22 06:48AM
Sep-22-22 04:30PM
Sep-15-22 08:30AM
Sep-08-22 04:30PM
Sep-07-22 08:30AM
Aug-11-22 04:31PM
Aug-09-22 07:24AM
Jul-12-22 08:07AM
May-25-22 10:13AM
08:47AM
May-18-22 09:30AM
May-12-22 04:30PM
May-11-22 07:34AM
May-10-22 11:10AM
May-08-22 09:00AM
May-06-22 09:37AM
May-03-22 10:06AM
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holuka Eugene MyronDirectorMar 13 '24Option Exercise0.012,415362,415Aug 30 04:01 PM
Webb CarolDirectorMar 04 '24Option Exercise0.0112,07118112,071Aug 30 04:01 PM